William Lewis McFarland II
Steven Wood Presley, William Lewis McFarland II, Alan Humes and Stephane Bellemare were appointed as the directors of the Company, effective as of the Effective Time.
Highest-materiality recent filing
SunOpta completes acquisition by Refresco affiliate for $6.50/share, going private
SunOpta acquired by Refresco affiliate for US$6.50 per Common Share in cash.
SunOpta shareholders approve $6.50/share acquisition by Refresco
98.06% of votes cast approved the acquisition by Refresco at US$6.50 per share.
SunOpta to be acquired by Pegasus BidCo for $6.50/share cash; deal expected Q2 2026
Consideration of $6.50 per common share in cash; total equity value not disclosed.
SunOpta raises FY2025 revenue outlook to $816-818M and Adj. EBITDA to $94-95M
Revenue outlook raised from $812-816M to $816-818M (~13% YoY growth).
SunOpta Q3 revenue +16.8% to $205.4M; cuts FY adj. EBITDA guidance to $90-92M
Revenue $205.4M (+16.8% YoY) on volume growth across beverages, broths, and fruit snacks.
SunOpta Q2 revenue +13% to $191.5M; adj. EBITDA +14%; reaffirms FY2025 outlook
Revenue $191.5M (+12.9% YoY) driven by 14.4% volume growth; adjusted EBITDA $22.7M (+13.9%).
SunOpta Q1 revenue up 9.3% to $202M; raises FY2025 outlook; authorizes $25M buyback
Revenue $201.6M (+9.3% YoY); volume growth 12.2% drives top line.
Revenue from continuing operations increased 8.9% to $193.9 million, driven by 12.8% volume growth.
SunOpta Q3 revenue up 15.5% to $176.2M; adjusted EBITDA up 12.6% to $21.5M; reaffirms FY outlook
Revenue $176.2M (+15.5% YoY) driven by 20.6% volume growth partially offset by 2.8% price reduction on pass-through commodity costs.
SunOpta Q2 rev up 21% to $171M; loss narrows to $3.8M; raises 2024 revenue guidance
Revenue $171M up 21% YoY driven by 26.9% volume growth; price reduction of 3.9% on pass-through commodities.
SunOpta Q1 rev $182.8M (+18%), EPS $0.03; raises FY2024 outlook
Revenue $182.8M, up 18% YoY from $155.0M, driven by 23.5% volume growth.
SunOpta Q4 revenue up 13.7% to $181.6M; Adj. EBITDA +17.5%; reaffirms 2024 outlook
Q4 revenue $181.6M, +13.7% YoY on 14.7% volume/mix growth; price -1.0%.
Steven Wood Presley, William Lewis McFarland II, Alan Humes and Stephane Bellemare were appointed as the directors of the Company, effective as of the Effective Time.
each of Dr. Albert Bolles, Rebecca Fisher, Dean Hollis, David J. Lemmon, Diego Reynoso, Leslie Starr and Mahes S. Wickramasinghe resigned as a member of the Company’s board of directors, and any committee thereof, effective as of the Effective Time.
each of Dr. Albert Bolles, Rebecca Fisher, Dean Hollis, David J. Lemmon, Diego Reynoso, Leslie Starr and Mahes S. Wickramasinghe resigned as a member of the Company’s board of directors, and any committee thereof, effective as of the Effective Time.
Steven Wood Presley, William Lewis McFarland II, Alan Humes and Stephane Bellemare were appointed as the directors of the Company, effective as of the Effective Time.
each of Dr. Albert Bolles, Rebecca Fisher, Dean Hollis, David J. Lemmon, Diego Reynoso, Leslie Starr and Mahes S. Wickramasinghe resigned as a member of the Company’s board of directors, and any committee thereof, effective as of the Effective Time.
each of Dr. Albert Bolles, Rebecca Fisher, Dean Hollis, David J. Lemmon, Diego Reynoso, Leslie Starr and Mahes S. Wickramasinghe resigned as a member of the Company’s board of directors, and any committee thereof, effective as of the Effective Time.
each of Dr. Albert Bolles, Rebecca Fisher, Dean Hollis, David J. Lemmon, Diego Reynoso, Leslie Starr and Mahes S. Wickramasinghe resigned as a member of the Company’s board of directors, and any committee thereof, effective as of the Effective Time.
Steven Wood Presley, William Lewis McFarland II, Alan Humes and Stephane Bellemare were appointed as the directors of the Company, effective as of the Effective Time.
each of Dr. Albert Bolles, Rebecca Fisher, Dean Hollis, David J. Lemmon, Diego Reynoso, Leslie Starr and Mahes S. Wickramasinghe resigned as a member of the Company’s board of directors, and any committee thereof, effective as of the Effective Time.
each of Dr. Albert Bolles, Rebecca Fisher, Dean Hollis, David J. Lemmon, Diego Reynoso, Leslie Starr and Mahes S. Wickramasinghe resigned as a member of the Company’s board of directors, and any committee thereof, effective as of the Effective Time.
Steven Wood Presley, William Lewis McFarland II, Alan Humes and Stephane Bellemare were appointed as the directors of the Company, effective as of the Effective Time.
On September 13, 2024, Katrina Houde, notified SunOpta, Inc. ("SunOpta" or the "Company"), that she intends to resign from her position as a member of the Company's Board of Directors effective September 16, 2024, in order to focus on other opportunities.
Max materiality 1.00 · Median 0.72 · Most common event earnings